Holen Sie sich die Stockscreener-App
0.3376
8.76%
-0.0324
Handel nachbörslich:
.33
-0.0076
-2.25%
Schlusskurs vom Vortag:
$0.37
Offen:
$0.35
24-Stunden-Volumen:
73.65M
Relative Volume:
0.81
Marktkapitalisierung:
$63.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-121.02M
KGV:
-0.0181
EPS:
-18.6875
Netto-Cashflow:
$-114.09M
1W Leistung:
-44.80%
1M Leistung:
+79.29%
6M Leistung:
-51.07%
1J Leistung:
-97.46%
1-Tages-Spanne:
$0.3134
$0.3547
1-Wochen-Bereich:
$0.3134
$0.5297
52-Wochen-Spanne:
$0.118
$14.08
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Firmenname
Tonix Pharmaceuticals Holding Corp
Sektor
Branche
Telefon
212-980-9155
Adresse
26 MAIN STREET, SUITE 101, CHATHAM, NY
Vergleichen Sie TNXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
0.3376 | 63.10M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.76 | 105.27B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
712.40 | 78.29B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
626.31 | 37.45B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
237.97 | 30.69B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.95 | 27.32B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-04-18 | Eingeleitet | Noble Capital Markets | Outperform |
| 2019-04-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2017-08-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2016-09-07 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-02-17 | Bestätigt | Oppenheimer | Outperform |
| 2015-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-12 | Eingeleitet | Oppenheimer | Outperform |
| 2015-02-17 | Bestätigt | ROTH Capital | Buy |
| 2014-09-29 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in December - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.7%Should You Sell? - MarketBeat
This Micro Cap Is Getting Bid Up Prior To Opening Bell - MSN
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 2.6%Should You Sell? - MarketBeat
Certain Options of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com
Certain Common Stock of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.4%Time to Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.2%What's Next? - MarketBeat
FDA sets review goal date for Tonix fibromyalgia drug By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 26.8%Should You Sell? - MarketBeat
Tonix Pharma Awaits FDA Decision on TNX-102 SL - TipRanks
FDA sets review goal date for Tonix fibromyalgia drug - Investing.com
Tonix Pharmaceuticals Announces PDUFA Goal Date of August - GlobeNewswire
Tonix Pharmaceuticals' Groundbreaking Fibromyalgia Drug Gets FDA Fast Track & PDUFA Date - StockTitan
StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) - MarketBeat
Tonix Pharmaceuticals ups offering to $250 million - Investing.com India
Tonix Pharmaceuticals ups offering to $250 million By Investing.com - Investing.com Canada
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 11.3%Here's Why - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.7%Should You Sell? - MarketBeat
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Tonix Pharmaceuticals Holding Corp. Announces Fda Acceptance of the New Drug Application for Tnx-102 Sl for Fibromyalgia - Marketscreener.com
FDA accepts new fibromyalgia drug application from Tonix Pharma By Investing.com - Investing.com Australia
FDA Accepts NDA for Tonix’s Sleep-Improving Drug for Fibromyalgia - Sleep Review
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
TSX 60 Capped Index (TXCI) QuotePress Release - The Globe and Mail
Tonix Pharma’s TNX-102 SL Nears FDA Approval Milestone - TipRanks
Nasdaq 100 Index (IUXX) QuotePress Release - The Globe and Mail
What's Going On With Tonix Pharmaceuticals Stock Today? - Benzinga
FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL - Invezz
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Tonix Pharmaceuticals Gets FDA Review of Fibromyalgia Drug - Marketscreener.com
Tonix stock jumps on FDA review for pain drug (TNXP:NASDAQ) - Seeking Alpha
FDA accepts new fibromyalgia drug application from Tonix Pharma - Investing.com
Tonix Pharmaceuticals Announces FDA Acceptance of the New - GlobeNewswire
Tonix's Breakthrough Fibromyalgia Drug Takes Major Step Forward with FDA NDA Acceptance - StockTitan
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights - citybiz
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket - Benzinga
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News Summary - Benzinga
Certain Options of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 11-DEC-2024. - Marketscreener.com
Certain Common Stock of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 11-DEC-2024. - Marketscreener.com
Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers - BioSpace
Tranche Update on Tonix Pharmaceuticals Holding Corp.'s Equity Buyback Plan announced on January 25, 2023. - Marketscreener.com
Tranche Update on Tonix Pharmaceuticals Holding Corp.'s Equity Buyback Plan announced on September 6, 2024. - Marketscreener.com
Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires - GlobeNewswire
TNXP: NDA Filed for TNX-102 SL in Fibromyalgia… - Yahoo Finance
Tonix Pharmaceuticals Holding (STU:TPM0) Operating Income : €-74.27 Mil (TTM As of Sep. 2024) - GuruFocus.com
Tonix Pharmaceuticals Holding (STU:TPM0) EBITDA per Share : €-24.48 (TTM As of Sep. 2024) - GuruFocus.com
Tonix Pharmaceuticals Holding (FRA:TPM0) FCF Yield % : -195.15 (As of Dec. 01, 2024) - GuruFocus.com
Tonix Pharmaceuticals Holding (FRA:TPM0) EV-to-Revenue : 1.46 (As of Dec. 01, 2024) - GuruFocus.com
Tonix Pharmaceuticals Holding (STU:TPM0) Capex-to-Revenue : 0.00 (As of Sep. 2024) - GuruFocus.com
Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.14%
5.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):